FDA Approval Activities for this Drug
Carboplatin Injection USP, 50, 150 and 450 mg, Faulding Pharmaceutical ANDA 76-473 4/16/03
Carboplatin Injection USP, 50, 150 or 450 mg, American Pharmaceutical Partners, ANDA 76-235 5/22/02
Carboplatin Injection USP, 10 mgmL, Gensia Sicor ANDA 76-227 8/12/02
Carboplatin Injection USP, 50, 150 or 450 mg, Pharmachemie B.V. ANDA 76-162 1/14/03
Carboplatin Injection USP, 10 mg/mL, Bedford ANDA 76-039 6/6/03
Carboplatin Injection USP, 50, 150 & 450 mg, Bedford ANDA 76-099 Paraplatin (Carboplatin Aqueous) Solution Injection, Bristol-Myers Squibb Co. NDA 20-452 7/14/03 7/28/03
Paraplatin (Carboplatin) Injection Bristol-Myers Squibb NDA 19880/S011 2/14/02 3/8/02
Paraplatin (Carboplatin) Injection Bristol-Myers Squibb NDA 19880/S009 Paraplatin (Carboplatin Aqueous Solution) Injection, Bristol-Myers Squibb Co. Carboplatin Injection USP, Mayne Pharma,
For the latest approval information, locate this drug using this index.